BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Pain Therapeutics, Inc. (NQ: PTIE)
5.380 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(PTIE) Community Analysis from
Bulls REASONS TO BUY
April 20, 2014
(Jutia Group, 11/26/13)
[at Seeking Alpha] - Pain Therapeutics Inc. ( PTIE ) is a drug development company that will collect roughly a 20% U.S. royalty and a 10% foreign royalty on what I estimate to be $1.4 billion/year in sales if Pfizer ( PFE ... Read more on this. Pfizer Inc. (PFE), currently valued at [...]
(market folly, 10/5/11)
Craig Perry and Erez Kalir 's hedge fund Sabretooth Capital just filed a Form 4 with the SEC regarding shares of Pain Therapeutics (PTIE). Per the filing, they disclose that they sold 382,000...(read more)
(Stock Blog Hub, 6/27/11)
The US Food and Drug Administration recently dealt a blow to Pfizer (PFE) and Pain Therapeutics, Inc. (PTIE) by issuing a second complete response letter (CRL) for their...(read more)
Pain Therapeutics (PTIE) Company Overview

There is no analysis for PTIE yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here